Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01560585
Recruitment Status : Terminated
First Posted : March 22, 2012
Last Update Posted : August 28, 2014
Sponsor:
Information provided by (Responsible Party):
Alan Lerner, MD, University Hospitals Cleveland Medical Center